SELLAS Life Sciences Group SLS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 1.04 | 9 | -53.14 | -7 | -29.33 | 19 |
| 2024Q3 | 1.25 | 16 | -75.60 | -7 | -34.15 | 27 |
| 2024Q2 | 1.19 | 3 | -118.60 | -7 | -37.77 | 15 |
| 2024Q1 | 1.01 | 10 | -10 | -62.41 | 24 | |
| 2023Q4 | 1.06 | -8 | -8 | -113.75 | 6 | |
| 2023Q3 | 1.64 | -4 | -9 | -69.54 | 8 | |
| 2023Q2 | 1.57 | 5 | -98.16 | -9 | -37.09 | 19 |
| 2023Q1 | 1.43 | 13 | -123.16 | -11 | -44.35 | 29 |
| 2022Q4 | 2.36 | 5 | -104.55 | -9 | -38.86 | 21 |
| 2022Q3 | 2.02 | 13 | -44.37 | -7 | -24.13 | 26 |
| 2022Q2 | 2.23 | 19 | -72.91 | -8 | -31.37 | 32 |
| 2022Q1 | 6.68 | 4 | -137.40 | -17 | -70.19 | 21 |
| 2021Q4 | 5.53 | 20 | -28.10 | -7 | -20.55 | 26 |
| 2021Q3 | 9.16 | 27 | -23.61 | -7 | -17.37 | 38 |
| 2021Q2 | 11.10 | 33 | -14.84 | -5 | -10.96 | 44 |
| 2021Q1 | 8.54 | 29 | -8.48 | -2 | -5.55 | 41 |
| 2020Q4 | 5.81 | 28 | -20.70 | -4 | -11.51 | 46 |
| 2020Q3 | 2.65 | 8 | -76.26 | -4 | -27.09 | 19 |
| 2020Q2 | 2.93 | 4 | -74.72 | -4 | -28.06 | 15 |
| 2020Q1 | 1.73 | 8 | -58.54 | -4 | -24.64 | 17 |